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Mesenchymal stem cell (MSC)–based tissue-engineered construct (TEC)–hydroxyapatite (HAp) composites were
developed by an alternate soaking process. The TEC derived from cultured synovial MSCs was alternately
immersed in varying concentrations of CaCl2=Tris-HCl and Na2HPO4=Tris-HCl buffers, and HAp formation
was analyzed by Fourier transform infrared spectroscopy (FT-IR), wide-angle X-ray diffraction, and scanning
electron microscopy (SEM). These analyses clearly demonstrated HAp formation in the TEC. Specifically, SEM
assessments showed that spherical HAp crystals of *1 mm were directly formed on the surfaces of the cells and
extracellular matrix (ECM) fibers. Cytotoxicity from exposure to calcium or phosphate buffers of >100 mM
concentrations as assessed by LIVE=DEAD staining and total DNA assays was detected, but such cytotoxicity
was not detected following exposure to concentrations of <50 mM. The HAp nanocrystals (ca. *500 nm) were
formed after 20 cycles in 10 mM calcium or phosphate buffers, and cell survival in the composites was con-
firmed. Moreover, preliminary implantation of TEC-HAp composites derived from rabbit synovial MSCs to
rabbit osteochondral defects exhibited accelerated osteoinduction. These composites may be the first example of
a hybrid material that consists of ECM, HAp nanocrystals, and living MSCs, and the TEC-HAp composite could
be a unique and useful material for bone tissue engineering.
Introduction
In clinical settings, autologous bone grafts are widelyused to repair defects; however, mismatch in size between
the donor and recipient site, and moreover potential risk of
donor site morbidity may limit their use. A number of bio-
materials have been developed for potential use in bone tissue
engineering. Hydroxyapatite (HAp), Ca10(PO4)6(OH)2, is one
of the more attractive materials for such artificial bone appli-
cations because of its biocompatibility, the absence of in-
flammatory or foreign body responses, and the fact that it is of
similar crystalline phase as bone mineral.1,2 However, a dis-
advantage of HAp is its mechanical properties, such as higher
stiffness, brittleness, and crystallinity, as compared with nat-
ural bone, which give rise to concerns with regard to clinical
use. Thus, researchers have studied hybrid materials composed
of HAp and polymeric biomaterials, such as poly(l-lactic
acid),3 poly(lactic-co-glycolic acid),4 cellulose,5,6 gelatin,7,8
poly(ethylene glutarate),9 and collagen,10,11 to modify its me-
chanical properties and functionality. However, the use of these
polymeric materials still carries risks of long-term side effects,
such as immunogenicity, disease transmission, or inflammation
during the hydrolysis process in the transplanted sites.12 In
order to avoid such unknown risks, polymeric materials
should be minimally combined with HAp. One interesting
option in this quest to enhance bone formation is a combination
of mesenchymal stem cells (MSCs) with a HAp-based scaffold.
Adding bone marrow–derived MSCs directly with a HAp
scaffold has been studied, and a positive effect of MSCs on
osteogenic capacity has been demonstrated.13 An obvious next
step would be the development of a HAp-based hybrid material
in combination with a more natural MSC-generated matrix.
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We have recently developed a novel scaffold-free tissue-
engineered construct (TEC) composed of cultured MSCs and
the extracellular matrices (ECMs) produced by the cells.14
TEC containing MSCs at high density exhibited an efficient
osteogenic differentiation capability (W. Ando et al., sub-
mitted), and therefore such TEC may be starting point for
further development of a potential material for bone tissue
engineering. However, the TEC requires a specific osteo-
inductive growth medium or supplementation with humoral
factors such as bone morphogenetic protein (BMP) for the
osteoinduction in vitro (W. Ando et al., unpublished data). As
the biological activity and safety of growth factors such as
BMP are not completely known yet, alternative methods to
stimulate osteoinduction of TEC are needed.
Taguchi et al. and Akashi and colleagues discovered an
alternate soaking process to simply and rapidly create bone-
like HAp on=in polymeric and metal materials (Fig. 1).15–19
HAp formation by this alternate soaking process was ap-
proximately 100 times faster than that of a biomimetic pro-
cess in simulated body fluid.20 Further, HAp–agarose gel
composites created by such an alternate soaking process had
low crystallinity and biodegradability, but effective osteo-
induction properties in periodontal tissue regeneration stu-
dies in vivo.17,19 In an extension of this approach, we
hypothesized that application of an alternate soaking process
to a previously described TEC would lead to development of
TEC-HAp composites that would enhance the osteoinductive
properties of a basic TEC.
In the present study, HAp crystals were deposited on the
surface of TEC generated from human synovial MSCs using
an alternate soaking process, and the process was optimized
by controlling the concentration of calcium=Tris-HCl and
phosphate=Tris-HCl buffers. Analogous TEC-HAp compo-
sites derived from rabbit synovial MSCs exhibited enhanced
osteoinductive properties in preliminary in vivo implantation
studies to repair osteochondral defects. Therefore, such TEC-
HAp composites represent a unique material for bone tissue
engineering and also for specific stem cell therapy.
Materials and Methods
Materials
All reagents were of the highest quality available and used
as purchased without further purification. Calcium chlo-
ride (CaCl2), disodium hydrogenphosphate (Na2HPO4), and
2-amino-2-hydroxymethyl-1,3-propanediol hydrochloride
(Tris-HCl) were purchased from Wako Pure Chemical
Industries (Osaka, Japan). l-Ascorbic acid 2-phosphate (Asc
2-P) was purchased from Sigma (St. Louis, MO). Solutions
of these chemicals were used after filtration for steriliza-
tion. High-glucose Dulbecco’s modified Eagle’s medium
(DMEM), Penicillin=Streptomycin, and trypsin-EDTA (0.25%
trypsin and 1 mM EDTA) were purchased from Gibco BRL,
Life Technologies (Rockville, MD). Collagenase for human
synovium was purchased from Worthington Biochemical
(Lakewood, NJ). Fetal bovine serum (FBS) was purchased
from Hyclone (Loga, UT). All other chemicals were pur-
chased from Nakarai Tesque (Kyoto, Japan).
Harvest of synovial tissue and isolation of MSCs
The harvesting and isolation of synovial cells were per-
formed based on our previous report.14 Briefly, human sy-
novial membranes from four male patients (average 28.8 [26–
33] years old) were obtained from arthroscopic surgeries of
the knee in accordance with a protocol approved by the in-
stitutional ethical committee. Rabbit synovial membranes
were also obtained aseptically from the knee joints of the
rabbit (male, 3 months old), postmortem within 12 h of death
and with institutional ethics approval. Synovial membrane
specimens of both species were rinsed with calcium- and
magnesium-free phosphate-buffered saline (PBS), minced
meticulously, and digested with 0.2% collagenase (Wor-
thington Biochemical) for 1.5 h at 378C. After neutralization of
the collagenase by growth medium containing high-glucose
DMEM (Gibco BRL) supplemented with 10% FBS (Hyclone)
and Penicillin=Streptomycin (Gibco BRL), the cells were
collected by centrifugation, washed with PBS, resuspended
in the growth medium, and plated in a T-25 culture flask.
For expansion, the cells were cultured in the growth med-
ium at 378C in a humidified atmosphere of 5% CO2. The
medium was replaced once per week. After 15–28 days of
primary culture, when the cells reached confluence, they were
washed with PBS, harvested by treatment with trypsin-EDTA
(Gibco BRL), and replated at a 1:3 dilution for the first sub-
culture. The cell passages were continued in the same manner
with 1:3 dilutions when the cells reached confluence. Cells at
passages 4 to 7 were used in this study. We have previously
confirmed that the obtained human synovial cells possessed
the characteristics of MSCs, such as cell surface antigen phe-
notype, renewal capacity, and pluripotency,14 and accord-
ingly the cells were designated to be synovial MSCs.
Development of the basic TEC
The synovial MSCs (passage¼ 5) were seeded onto six-
well culture dishes at a density of 4.0105 cells=cm2 in growth
medium with 0.2 mM Asc 2-P. After 7 days of cell culture, a
monolayer complex of cultured cells and ECM produced by
these cells was detached from the dish by the application of a
shear stress using gentle pipetting. The detached monolayer
complex was left in suspension to form a three-dimensional
(3D) structure by active tissue contraction. This tissue was
termed a basic scaffold-free 3D TEC.14
Alternate soaking protocol for TEC
The alternate soaking process was performed to form
HAp on the surface of the TEC as shown in Figure 1. At the
first step, the TEC from six-well culture dishes was soaked
in 10 mL of 10–200 mM CaCl2=50 mM Tris-HCl buffer
(pH¼ 7.4) at room temperature for 10 s, and washed to re-
FIG. 1. Scheme of the alternate soaking process used in this
study.
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move excess calcium ions by immersion in 10 mL of 50 mM
Tris-HCl buffer (pH¼ 7.4) for 10 s. Next, the TEC was soaked
in 10 mL of 10–200 mM Na2HPO4=50 mM Tris-HCl buffer
(pH¼ 7.4) at room temperature for 10 s and washed with
10 mL of 50 mM Tris-HCl buffer (pH¼ 7.4) for 10 s. These
steps represent one cycle. The alternate soaking process was
then repeated for a variable number of cycles as outlined in
specific experiments.
Characterization of the TEC-HAp composites
The TEC or TEC-HAp composites from 6-cm culture dishes
were freeze-dried for 3 days in order to measure the Fourier
transform infrared spectroscopy (FT-IR) spectrum, for X-ray
diffraction, and for scanning electron microscopy (SEM)
analyses. The IR spectrum of the dried TEC or TEC-HAp was
measured using a Spectrum One FT-IR Spectrometer (Perkin
Elmer Instruments, Beaconsfield, United Kingdom). The in-
terferograms were coded 16 times and Fourier transformed
at a resolution of 4 cm1. The wide-angle X-ray diffraction
(WAXD) studies were recorded using an X-ray diffracto-
meter RINT UltraX18 (Rigaku, Tokyo, Japan) equipped with
a scintillation counter and using CuKa radiation (40 kV,
200 mA; wavelength¼ 1.5418 A˚), which was monochromated
by a parabolic multilayer mirror in transmission geometry.
The surface morphologies of the samples were observed using
an SEM HITACHI S-800 (Hitachi, Tokyo, Japan).
LIVE-DEAD staining of TEC-HAp composites
To evaluate the viability of synovial MSCs after the
alternate soaking process with various concentrations of
calcium=Tris-HCl and phosphate=Tris-HCl buffers, the cells
(passage¼ 7) were adhered onto a cover glass (3.0104 cells=
cm2) for 24 h and then alternately soaked for predetermined
cycles. The cells were then stained by incubation in 1.0 mL of
PBS containing 2mM of calcein-AM and 4mM of ethidium
homodimer (EthD-1) (LIVE=DEAD Viability=Cytotoxicity
Kit [L-3224]; Invitrogen-Molecular Probes, Carlsbad, CA) for
45 min at 378C.21 The living cells stained with calcein-AM
exhibit a green color, whereas dead cells stained with EthD-1
exhibit a red color by fluorescence microscopy. The fluores-
cence microscopic images were taken with an Olympus
confocal disc scan system DSU-IX81-SET (Olympus, Tokyo,
Japan).
Total DNA content of TEC after exposure
to the alternate soaking process
The amount of DNA in the TEC from six-well culture
dishes after alternate soaking with various concentrations of
calcium=Tris-HCl and phosphate=Tris-HCl buffers was de-
termined with a DNA assay kit (DNeasy Tissue Kit; QIAGEN,
Hilden, Germany). The TEC was alternately soaked for 10 or
20 cycles in 10, 50, 100, or 200 mM CaCl2=50 mM Tris-HCl or
Na2HPO4=50 mM Tris-HCl buffer (pH¼ 7.4) at ambient tem-
perature, and the DNA in the TEC was extracted. The total
DNA content was subsequently measured with the DNA assay
kit.
WST-1 assay of TEC-HAp composites
The survival of human synovial MSCs in TEC after ex-
posure to the alternate soaking process was assessed by the
WST-1 assay, which is an improved version of the MTT as-
say.22 Briefly, 50mL of WST-1 reagent (DOJINDO Labora-
tories, Kumamoto, Japan) was added to dishes containing
the TEC-HAp composites from six-well culture dishes and
5 mL of Eagle’s MEM (10% FBS) without phenol red, and the
dishes were incubated for 3 h at 378C. The WST-1 reagent
was transformed into WST-1 formazan during the incuba-
tion by dehydrogenase that is synthesized by living cells,
and thus produced the yellow-colored WST-1 formazan. The
image of the TEC-HAp with yellow-colored formazan was
taken using a digital still camera, DSC-F505V Cyber-shot
(SONY, Tokyo, Japan).
Implantation of TEC-HAp composites derived from
rabbit MSCs into osteochondral defects in vivo
Similar to the human synovial MSCs, rabbit synovial MSCs
(passages 4–7) were prepared and further cultured at the
density of 4.0105 cells=cm2 with Asc 2-P in 6-cm-diameter
culture dishes for 7 days, and the resultant basic TEC was
prepared as allografts without any osteoinductive stimulation.
TEC-HAp was prepared by 20 cycles of alternate soaking
processes with 10 mM calcium=Tris-HCl and phosphate=Tris-
HCl buffers. Female, one-year-old skeletally mature Japanese
white rabbits (n¼ 3) were anesthetized by intramuscular in-
jection of a mixture of ketamine hydrochloride (50 mg=mL and
0.6 mL=kg of body weight) and xylazine (20 mg=mL and
0.3 mL=kg of body weight). After a medial parapatella inci-
sion, the medial femoral condyles of both knees were exposed
with the knee in deep flexion, and osteochondral defects were
created that were 4.0 mm in diameter and 4.0 mm in depth
using an electric router (Proxxon, Niersbach, Germany) and
diamond disc grinding (Shofu, Kyoto, Japan). Subsequently,
the basic TEC (to the right knee) or TEC-HAp (to the left knee)
was implanted without suturing into the defect sites. Both
legs were casted for immobilization for 1 week, and the rabbits
were then returned to free cage activity. Six weeks post-
operatively, the rabbits were euthanized under anesthesia.
The femurs were dissected, and scanned using a microfocus
X-ray CT system SMX-100CT-SV (Shimazu, Kyoto, Japan) for
microcomputed tomography (mCT) analysis. The data were
reconstructed to produce images of the tibia, using 3D visual-
ization and measurement software (Vay Tek).23 After mCT
analysis, the femurs were fixed and used for subsequent
paraffin sectioning and histological analysis. Tissues were fixed
with 4% paraformaldehyde in phosphate buffer (pH¼ 7.4),
decalcified with EDTA, embedded in paraffin, and 4-mm sec-
tions were prepared. The sections were stained with hema-
toxylin and eosin.
Statistical analysis
Data were compared using one-way analysis of variance
(ANOVA) with multiple comparison analysis performed
using a two-sample t-test for each comparison with the
control. P values less than or equal to 0.01 were considered
statistically significant.
Results and Discussion
Fabrication of the TEC-HAp composite materials
HAp was deposited on the surface of human TEC using an
alternate soaking process with the TEC alternately soaked in
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calcium=Tris-HCl and phosphate=Tris-HCl buffers for a pre-
determined number of cycles. Figure 2 shows the macro-
scopic appearance of the TEC before and after the alternate
soaking process. Although the original TEC was a trans-
parent and soft film (Fig. 2A), it changed to a more white
color depending on the number of alternate soaking cycles to
which the it was exposed (Fig. 2B, C). After 20 cycles, the
TEC was completely white in color and firm to touch. These
observations suggested that calcium phosphate was formed
on the surface of the TEC. To determine whether the crys-
tallographic structure of the calcium phosphate was HAp,
octacalcium phosphate (OCP), or b-tricalcium phosphate, the
crystallographic structure of the calcium phosphate formed
on the TEC was assessed by FT-IR spectroscopy and X-ray
diffraction. Figure 3 shows the FT-IR spectra of the TEC
before and after the alternate soaking process. The IR peaks
assigned to the stretching vibration of the phosphate groups
in HAp (PO4
3: 560, 600, 960, and 1095 cm1) appeared after
the alternate soaking process, and the absorbance of the IR
peaks increased with an increasing number of alternate
soaking process cycles (Fig. 3B–D). The IR peak assigned to
the stretching vibration of the phosphate groups in OCP
(PO4
3: 1020 cm1) also appeared after 20 cycles of the al-
ternate soaking process (Fig. 3D). WAXD patterns are shown
in Figure 4. After alternate soaking of TEC for 0, 5, and 10
cycles, no definite diffraction peaks were observed. The de-
finite diffraction peaks assigned to the d spacing of the HAp
crystal at 10.88 (d100: 8.17 A˚), 21.88 (d200: 4.07 A˚), 22.98 (d111:
3.88 A˚), 25.98 (d002: 3.44 A˚), 31.88 (d211: 2.81 A˚), and 39.88
(d310: 2.26 A˚) were observed after 20 cycles of the alternate
soaking process (Fig. 4D). The peak at 11.38 corresponding to
d200 of OCP at 9.34 A˚ was also observed, but not as clearly as
those for HAp. These results of the FT-IR and WAXD ana-
lyses suggest that the calcium phosphates formed on the
surface of TEC were likely mainly HAp, and potentially,
partly OCP. Since HAp is thermodynamically the most stable
FIG. 2. Macroscopic observations of the TEC (A) before
and after (B) 5 and (C) 20 cycles of alternate soaking in
200 mM CaCl2=50 mM Tris-HCl buffer (pH¼ 7.4) and
120 mM Na2HPO4=50 mM Tris-HCl buffer (pH¼ 7.4). The
scale bars in (A) and (B) are 1 cm, and scale bar is 2 cm in
(C), respectively.
FIG. 3. FT-IR spectra of the TEC (A) before and after (B) 5,
(C) 10, and (D) 20 cycles of alternate soaking in 200 mM
CaCl2=50 mM Tris-HCl buffer (pH¼ 7.4) and 120 mM
Na2HPO4=50 mM Tris-HCl buffer (pH¼ 7.4).
FIG. 4. WAXD patterns of the TEC (A) before and after (B)
5, (C) 10, and (D) 20 cycles of alternate soaking in 200 mM
CaCl2=50 mM Tris-HCl buffer (pH¼ 7.4) and 120 mM
Na2HPO4=50 mM Tris-HCl buffer (pH¼ 7.4).
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form of calcium phosphate in a natural environment, this
may explain why the predominant calcium phosphate
formed on the TEC was due to HAp crystals.
The morphology of the HAp crystals formed on TEC was
also assessed by SEM. Figure 5 shows SEM images of TEC
before and after 20 cycles of the alternate soaking process. The
original TEC was a composite film of cells and ECM fibrils
(Fig. 5A), but spherical HAp crystals of approximately 1-mm
diameter were observed to densely form on the TEC after the
alternate soaking process (Fig. 5B). Further assessment of
higher magnification images indicated that the spherical HAp
crystals actually consisted of stick-like crystals of 50- to 100-
nm lengths (Fig. 5C). We have previously reported spherical
HAp crystal formation on=in agarose hydrogels using this
alternate soaking process,17,24 and the sizes of the HAp crys-
tals (ca. 200 nm) in that study were smaller than those seen in
the present study. Thus, the size and morphology of the HAp
crystals formed by the alternate soaking process appears to be
influenced by the composition of the materials to which they
adhere. In the case of a platinum plate as the substrate, irre-
gular crystals of HAp formed on the surface of the platinum
plate,18 whereas spherical HAp crystals formed on=in organic
materials, such as agarose,17,24 poly(vinyl alcohol),16 and the
TEC. A conventional HAp–polymer composite material
only allows cell adhesion on the surface of the HAp crystals,
and the direct formation of HAp crystals on the surface of
living cells has rarely been reported. Therefore, this study
may be the first report of direct HAp formation on the cell
surface.
Effect of concentration of calcium and phosphate
buffers on cell viability
In light of the above findings, the viability of synovial
MSCs in the TEC was investigated after the alternate soaking
process. Because the HAp crystals appeared to be directly
formed on the surface of the MSCs, it was possible that such
HAp crystal formation could subsequently influence TEC
cell viability. The viability of human synovial MSCs adhered
onto a coverslip after the alternate soaking process with
various concentrations of calcium=Tris-HCl and phosphate=
Tris-HCl buffers was assessed by the LIVE=DEAD assay,
which stains living and dead cells as green and red, respec-
tively, on fluorescence microscopic observation. In buffer
concentrations of< 50 mM, almost all cells were green, thus
suggesting good survival of the cells (Fig. 6A–C). On the
other hand, red-colored cells were clearly observed at buffer
concentrations>100 mM (Fig. 6D–E), indicating the presence
of dead cells after only three cycles of alternate soaking in the
200 mM buffer (Fig. 6E). These results suggested that higher
concentrations of calcium=Tris-HCl and phosphate=Tris-HCl
buffers exert a cytotoxic effect on the cells. In order to
quantitatively evaluate cell viability, a total DNA analysis of
the TEC after the alternate soaking process was performed.
Figure 7 shows the total DNA content of TEC after the
alternate soaking process in various concentrations of
calcium=Tris-HCl and phosphate=Tris-HCl buffers. As a con-
trol, we confirmed that the DNA content of TEC after im-
mersion in only Tris buffer for 20 min (equal to elapsed time
of 20 cycles) yielded nearly the same values as the original
TEC without any immersion. The mean DNA content of the
original TEC without any alternate soaking (0 cycle; control)
was approximately 26mg, and no statistically significant
differences in total DNA content were detected after 10 or 20
cycles of alternate soaking in the 10 and 50 mM calcium and
phosphate buffers. However, statistically significant de-
creases in DNA content were observed after exposure to the
100 mM buffer, and the DNA content of TEC decreased
by>50% after the alternate soaking process in 200 mM buffer
(yields after 10 and 20 cycles were 13.4 and 5.4 mg DNA,
FIG. 5. SEM images of the TEC (A) be-
fore and (B) after 20 cycles of alternate
soaking in 200 mM CaCl2=50 mM Tris-
HCl buffer (pH¼ 7.4) and 120 mM
Na2HPO4=50 mM Tris-HCl buffer
(pH¼ 7.4). Image (C) shows a higher
magnification of that in (B). The inset in
(B) shows a spherical HAp crystal, while
image in (C) shows that the crystals in (B)
are actually composed of stick-like crystals
of 50–100 nm. The scale bars in (A), (B),
and (C) are 50 mm, 5mm, and 500 nm, re-
spectively, and the inset scale bar is 1 mm.
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respectively). Statistically significant differences in DNA
content were detected after 10 compared to 20 cycles in
200 mM buffer ( p< 0.01). These results clearly confirmed
the cytotoxicity of the calcium and phosphate buffers at
concentrations>100 mM. Recently, Maeno et al. reported the
effects of calcium ion concentrations on osteoblast viability in
2D and 3D cultures.25 They reported that concentrations of
calcium ion over 10 mM in the culture media exhibited cyto-
toxicity for osteoblast cultures after 7 days of incubation. In
the present study, although the synovial MSCs in the TEC
were immersed in the calcium and phosphate buffers for
only 10 s, high concentrations (>100 mM) of calcium buffer
showed definite cytotoxicity. Therefore, since the cytotoxicity
was not observed at concentrations below 50 mM even after
20 cycles, the TEC-HAp composites with living cells should
be developed using low concentrations of calcium and
phosphate buffers.
TEC-HAp composite materials with living cells
Based on the above results, 20 cycles of alternate soaking
of the TEC using 10 mM calcium=Tris-HCl and phosphate=
Tris-HCl buffers were performed to avoid cytotoxicity.
Figure 8A and B shows SEM images of the resultant TEC-
HAp composite surfaces. Approximately 500-nm-diameter
spherical HAp nanocrystals were observed on the surface of
the cells and ECM fibers, and the HAp crystals were sparsely
distributed on the TEC. However, a very dense deposition of
HAp crystals (the size was ca. 1mm) was observed after 20
cycles at the 200 mM concentration (Fig. 5B). The crystal-
lographic structure of the HAp formed on the TEC under
these conditions was confirmed by FT-IR spectroscopy and
the WAXD pattern (Fig. 8C, D). These results suggest that the
size of the HAp crystals could be controlled by varying
FIG. 7. Total DNA content of the TEC after the alternate
soaking process in various concentrations of CaCl2=50 mM
Tris-HCl buffer (pH¼ 7.4) and Na2HPO4=50 mM Tris-HCl
buffer (pH¼ 7.4) (n¼ 3). The TEC without any alternate
soaking (0 cycle) represents the control. Asterisk (*) indicates
statistically significant difference ( p< 0.01) using a two-
sample t-test for each comparison with the control. Statisti-
cally significant differences in DNA content were detected
after 10 versus 20 cycles in 200 mM buffer (**p< 0.01).
FIG. 6. Fluorescence microscopic images of (A) the synovial cells, and (B–F) the alternately soaked cells with various
concentrations of CaCl2=50 mM Tris-HCl buffer (pH¼ 7.4) and Na2HPO4=50 mM Tris-HCl buffer (pH¼ 7.4). (B) 20 cycles in
10 mM, (C) 10 cycles in 50 mM, (D) 10 cycles in 100 mM, (E) 3 cycles in 200 mM, and (F) 10 cycles in 200 mM buffer. The cells
were labeled with calcein-AM and EthD-1 after the alternate soaking process. All scale bars are 100 mm. Color images
available online at www.liebertonline.com/ten.
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the concentration of the calcium and phosphate buffers in the
alternate soaking process. Since the mean DNA content of
the TEC-HAp composite generated with the 20 cycles of the
10 mM buffer was 23.9 mg, approximately the same as the
original TEC, the cells were also maintained in a viable state.
To visually evaluate the living cells in the TEC-HAp com-
posite, the WST-1 method was used. Figure 9 is a photograph
of a TEC-HAp composite stained with WST-1 formazan. The
composite was clearly yellow, suggesting that the cells pre-
sent in the composite are living. These findings indicated that
TEC-HAp composites composed of living human synovial
MSCs, and HAp nanocrystals can be directly formed on the
cell surface by optimization of the buffer concentrations.
Early effect of rabbit TEC-HAp on bone repair
Finally, we performed preliminary in vivo implantation
experiments with rabbit TEC-HAp composites to assess their
potential to repair bony defects in the medial femoral con-
dyle of skeletally mature rabbits. When assessed at 6 weeks
postsurgery, immediate implantation of basic TEC into de-
fects initiated repair with a resultant fibrous tissue (Fig. 10A,
C, and E). Conversely, implantation of TEC-HAp composites
clearly induced osteogenesis (indicated by the arrows at the
bottom of bone defect sites; Fig. 10B, D, and F). Although the
long-term detailed implantation experiments of rabbit TEC-
HAp composites are now in progress, the present results
strongly suggest that TEC-HAp composites exhibit an en-
hanced osteoinductive capacity in vivo as compared with the
basic TEC. Therefore, it is likely that HAp deposition re-
sulted in the enhancement of osteoinduction by the TEC, and
thus TEC-HAp composites could be a unique and promising
material for bone tissue engineering.
Conclusions
In summary, TEC-HAp composites were successfully de-
veloped by an alternate soaking process. Spherical HAp
crystals were formed directly on the surface of the synovial
MSCs and ECM fibers. Further, the resultant cell viability
was controllable by adjusting the concentration of the calcium
and phosphate buffers. Moreover, preliminary studies re-
vealed that TEC-HAp composites show definite osteoinduc-
tion properties in vivo. To the best of our knowledge, this is
the first example of a HAp nanocomposite material com-
posed of living MSCs, ECM fibers, and HAp nanocrystals.
FIG. 8. (A, B) SEM images,
(C) FT-IR spectrum, and (D)
WAXD pattern of the TEC
after 20 cycles of alternate
soaking in 10 mM
CaCl2=50 mM Tris-HCl and
Na2HPO4=50 mM Tris-HCl
buffers (pH¼ 7.4). In (A) and
(B), the arrows indicate HAp
crystals. The scale bars are 20
and 10 mm in (A) and (B),
respectively.
FIG. 9. Photograph of the TEC stained with WST-1 for-
mazan after 20 cycles of alternate soaking in 10 mM CaCl2=50
mM Tris-HCl buffer (pH¼ 7.4) and 10 mM Na2HPO4=
50 mM Tris-HCl buffer (pH¼ 7.4). Color images available
online at www.liebertonline.com/ten.
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Further, we have also confirmed that human serum is no less
effective than bovine serum in promoting proliferation of
synovium-derived MSCs without compromising the differ-
entiation potential of the cells.26 With the use of autologous
human serum, it is technically possible to develop xeno-free
TEC-HAp composites. Thus, such composites have great
potential as a unique, safe, and promising implantable ma-
terial for bone tissue engineering.
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